Metronidazole Norma

Metronidazole, the active ingredient in Metronidazole Norma, is a nitroimidazole antibiotic presented as an intravenous solution for intravenous use. It treats anaerobic bacterial infections and certain protozoal diseases in both adult and pediatric patients as prescribed by a healthcare professional.

GNH USA supplies Metronidazole Norma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. Customers benefit from consistent product availability and regulatory compliance across multiple markets.

Metronidazole is used to treat infections caused by anaerobic bacteria and certain protozoa.

- Anaerobic bacterial infections: effective against mixed anaerobic flora, reducing infection severity. - Intra-abdominal infections: controls polymicrobial infections within the abdominal cavity. - Pelvic inflammatory disease: eradicates causative anaerobes, improving pelvic health. - Bacterial vaginosis: restores normal vaginal flora by eliminating overgrowth. - Clostridioides difficile infection (adjunct): used alongside standard therapy to reduce recurrence risk. - Amoebiasis: eliminates Entamoeba histolytica trophozoites in intestinal disease.

Metronidazole may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: mild stomach upset often reported. - Metallic taste: transient metallic sensation in the mouth. - Headache: mild to moderate headache episodes. - Diarrhea: loose stools occurring during therapy.

Serious or Rare Side Effects: - Seizures: rare convulsions requiring immediate medical attention. - Peripheral neuropathy: tingling or numbness in extremities, potentially persistent. - Severe allergic reactions: rash, swelling, or anaphylaxis.

Before initiating Metronidazole therapy, clinicians should consider several precautionary measures to ensure safe use.

- Assess renal function: adjust dosage in patients with significant impairment. - Monitor hepatic function: use cautiously in liver disease due to metabolism. - Avoid alcohol: risk of disulfiram‑like reaction causing flushing and tachycardia. - Use with caution in pregnancy: limited safety data, weigh benefits against risks. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Metronidazole can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Alcohol: may cause severe disulfiram‑like reaction. - Warfarin: potentiates anticoagulant effect, increasing bleeding risk. - Lithium: can raise lithium levels, leading to toxicity.

Moderate Interactions (Monitor Closely): - Phenytoin: may lower metronidazole concentrations. - Cimetidine: can increase metronidazole plasma levels. - Theophylline: possible elevation of theophylline concentrations.